AAAAAA
Results:
1-12
|
Results: 12
Authors:
BUER J
PROBST M
DUENSING S
KODITZ H
FRANZKE A
DALLMANN I
GANSER A
ATZPODIEN J
Citation: J. Buer et al., CLINICAL AND IN-VITRO RESPONSE TO 13-CIS-RETINOIC ACID IN INTERFERON-ALPHA RESISTANT RENAL-CELL CARCINOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(3), 1997, pp. 143-147
Authors:
KUNTER U
BUER J
PROBST M
DUENSING S
DALLMANN I
GROSSE J
KIRCHNER H
SCHLUEPEN EM
VOLKENANDT M
GANSER A
ATZPODIEN J
Citation: U. Kunter et al., PERIPHERAL-BLOOD TYROSINASE MESSENGER-RNA DETECTION AND SURVIVAL IN MALIGNANT-MELANOMA, Journal of the National Cancer Institute, 88(9), 1996, pp. 590-594
Authors:
ANASTASSIOU G
DUENSING S
STEINHOFF G
ZORN U
GROSSE J
DALLMANN I
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: G. Anastassiou et al., PLATELET ENDOTHELIAL-CELL ADHESION MOLECULE-1 (PECAM-1) - A POTENTIALPROGNOSTIC MARKER INVOLVED IN LEUKOCYTE INFILTRATION OF RENAL-CELL CARCINOMA, Oncology, 53(2), 1996, pp. 127-132
Authors:
BUER J
HILSE R
DALLMANN I
GROSSE J
KIRCHNER H
ZORN U
HANNINEN EL
FRANZKE A
DUENSING S
POLIWODA H
ATZPODIEN J
Citation: J. Buer et al., LYMPHOCYTE-CONDITIONED MEDIUM IN COMBINATION WITH INTERLEUKIN-2 EFFECTIVELY INDUCES ANTITUMOR AUTOIMMUNITY BY ADOPTIVE TRANSFER OF SHORT ACTIVATED KILLER (SHAK) CELLS, Cytokines and molecular therapy, 1(1), 1995, pp. 39-46
Authors:
MEFFERT M
SCHOMBURG A
HANNINEN EL
MENZEL T
VOCKE S
DALLMANN I
GROSSE J
DUENSING S
BUER J
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Meffert et al., IN-VIVO TUMOR-NECROSIS-FACTOR-ALPHA AS INDICATOR OF BIOLOGIC AND CLINICAL-RESPONSE TO LOW-DOSE SC RECOMBINANT INTERLEUKIN-2, Anticancer research, 15(1), 1995, pp. 127-132
Authors:
MEFFERT M
HANNINEN EL
MENZEL T
SCHOMBURG A
DUENSING S
DALLMANN I
GROSSE J
VOCKE S
BUER J
DECKERT M
HILSE R
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Meffert et al., IN-VIVO TIME AND DOSE-DEPENDENCY OF INTERLEUKIN-6 SECRETION IN RESPONSE TO LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2, Cancer biotherapy, 9(4), 1994, pp. 307-316
Authors:
ZORN U
DALLMANN I
GROSSE J
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: U. Zorn et al., INDUCTION OF CYTOKINES AND CYTOTOXICITY AGAINST TUMOR-CELLS BY NEWCASTLE-DISEASE VIRUS, Cancer biotherapy, 9(3), 1994, pp. 225-235
Authors:
ZORN U
DALLMANN I
GROSSE J
KIRCHNER H
ATZPODIEN J
Citation: U. Zorn et al., SOLUBLE INTERLEUKIN-2 RECEPTORS ABROGATE IL-2 INDUCED ACTIVATION OF PERIPHERAL MONONUCLEAR-CELLS, Cytokine, 6(4), 1994, pp. 358-364
Authors:
DUENSING S
DALLMANN I
GROSSE J
BUER J
HANNINEN EL
DECKERT M
STORKEL S
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: S. Duensing et al., IMMUNOCYTOCHEMICAL DETECTION OF P-GLYCOPROTEIN - INITIAL EXPRESSION CORRELATES WITH SURVIVAL IN RENAL-CELL CARCINOMA PATIENTS, Oncology, 51(4), 1994, pp. 309-313
Authors:
MENZEL T
SCHOMBURG A
KORFER A
HADAM M
MEFFERT M
DALLMANN I
CASPER S
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: T. Menzel et al., CLINICAL AND PRECLINICAL EVALUATION OF RECOMBINANT PEG-IL-2 IN HUMAN, Cancer biotherapy, 8(3), 1993, pp. 199-212
Authors:
ATZPODIEN J
KIRCHNER H
KORFER A
HADAM M
SCHOMBURG A
MENZEL T
DECKERT M
FRANZKE A
VOLKENANDT M
DALLMANN I
GROSSE J
POLIWODA H
Citation: J. Atzpodien et al., EXPANSION OF PERIPHERAL-BLOOD NATURAL-KILLER-CELLS CORRELATES WITH CLINICAL OUTCOME IN CANCER-PATIENTS RECEIVING RECOMBINANT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA(2), Tumor biology, 14(6), 1993, pp. 354-359
Authors:
SCHNEEKLOTH C
KORFER A
HADAM M
HANNINEN EL
MENZEL T
SCHOMBURG A
DALLMANN I
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: C. Schneekloth et al., LOW-DOSE INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA EFFECTIVELY MODULATES BIOLOGICAL RESPONSE INVIVO, Acta haematologica, 89(1), 1993, pp. 13-21
Risultati:
1-12
|